• Ciprofloxacin (hydrochloride) in Cell-Based Assays: Lab-Read

  2026-04-20

  This article delivers scenario-driven guidance for researchers and technicians seeking reproducible, quantitative results with Ciprofloxacin (hydrochloride) (SKU C5539). By addressing real-world assay pitfalls, compatibility, and vendor reliability, it distills best practices and highlights how APExBIO’s formulation ensures data integrity and workflow efficiency.

• Systematic Review of Entecavir vs. Lamivudine in Acute Hepat

  2026-04-20

  This article analyzes a systematic review and meta-analysis comparing Entecavir and lamivudine for acute hepatitis B, focusing on efficacy, seroconversion rates, and safety. It discusses the paper’s methodological approach and implications for research and clinical practice.

• CerS6-Driven Ceramide Metabolism in Stress-Induced Liver Inj

  2026-04-19

  Liu et al. (2024) elucidate the mechanistic link between restraint stress, ceramide metabolism disorders, and mitochondrial injury in rat liver, emphasizing the pivotal role of CerS6-derived C16:0 ceramide and AMPK/p38 MAPK signaling. These findings clarify how stress-induced signaling cascades compromise hepatocyte viability and highlight methodological strategies for maintaining phosphorylation integrity during pathway analysis.

• Caveolin-1 Regulates Cholesterol Homeostasis in MASLD Progre

  2026-04-18

  This study uncovers how Caveolin-1 (CAV1) mitigates the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) by restoring cholesterol homeostasis and reducing ER stress and pyroptosis. The findings provide mechanistic insights into the role of CAV1 in hepatic cholesterol regulation, suggesting new avenues for research and intervention.

• Spiroplasma eriocheiris Entry in Drosophila S2 Cells: Endocy

  2026-04-17

  This study reveals that Spiroplasma eriocheiris relies on clathrin-mediated endocytosis and macropinocytosis to enter Drosophila Schneider 2 (S2) cells, inducing apoptosis and extensive cytoskeletal rearrangement. These insights clarify pathogen-host interactions in invertebrate systems and provide a methodological basis for dissecting endocytic pathways during bacterial infection.

• One-step TUNEL FITC Apoptosis Detection Kit in Immune Cell D

  2026-04-16

  Explore the One-step TUNEL FITC Apoptosis Detection Kit for advanced detection of apoptotic DNA fragmentation. This article uniquely connects the kit’s utility to recent discoveries in immune cell death pathways and assay decision-making.

• Fluorinated CXCR4 Inhibitor A1 Advances Colorectal Cancer Th

  2026-04-15

  Khorramdelazad et al. introduce A1, a novel fluorinated CXCR4 antagonist, and demonstrate its superior efficacy over AMD3100 in colorectal cancer models. Their integrative approach reveals A1’s potential to more effectively inhibit tumor progression and modulate the tumor microenvironment, offering promising translational implications.

• Z-IETD-FMK: Unlocking Caspase-8 Inhibition for Translational

  2026-04-14

  This thought-leadership article dissects the mechanistic and translational significance of Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone), a potent and specific caspase-8 inhibitor, in immune signaling and apoptosis research. By synthesizing cutting-edge evidence—including recent mitochondrial apoptosis studies—and strategic insights from the competitive landscape, we provide actionable guidance for translational researchers aiming to innovate in immune modulation, disease modeling, and therapeutic development.

• Structural Insights into Tiamulin–Ribosome Interactions and

  2026-04-13

  This article analyzes how Tiamulin and related pleuromutilin antibiotics interact with the bacterial ribosome’s peptidyl transferase center, as elucidated by chemical footprinting and structural studies. The findings clarify resistance mechanisms at the molecular level and inform rational design strategies for next-generation veterinary antibiotics.

• Pharmacological and Clinical Advances of Palonosetron Hydroc

  2026-04-12

  This article reviews the pharmacological, pharmacokinetic, and clinical profile of palonosetron hydrochloride, a highly selective 5-HT3 receptor antagonist. Key innovations include its extended half-life, superior receptor selectivity, and clinically validated efficacy for both acute and delayed chemotherapy-induced nausea and vomiting.

• Angiotensin II in Endothelial Function: A Research-Grade Per

  2026-04-12

  Explore the role of Angiotensin II in endothelial dysfunction and hypertension, with a focus on translational research and advanced applications. This article provides unique, assay-relevant insights for vascular biology using Angiotensin II peptide.

• Dlin-MC3-DMA: Advancing Ionizable Cationic Liposome Workflow

  2026-04-11

  Dlin-MC3-DMA redefines ionizable cationic liposome performance for nucleic acid delivery, enabling high-potency, low-toxicity siRNA and mRNA workflows. Discover robust protocol optimizations, comparative data, and troubleshooting strategies to maximize your LNP-based gene silencing or vaccine research.

• Merimepodib (VX-497): Protocols and Innovation in Virology &

  2026-04-11

  Merimepodib (VX-497) redefines experimental control in cancer, immunology, and virology by targeting IMPDH with unmatched specificity. Explore workflow-driven applications, troubleshooting, and the latest evidence—especially its pivotal role in host-directed antiviral strategies. APExBIO delivers research-grade Merimepodib for reproducible, translational breakthroughs.

• Optimizing Lab Assays with Diclofenac (SKU B3505): Practi...

  2026-04-10

  This article equips biomedical researchers and lab technicians with scenario-driven, evidence-based guidance for deploying Diclofenac (SKU B3505) in cell viability, cytotoxicity, and pharmacokinetic assays. By addressing common challenges—from compound solubility to reliable vendor selection—the guide demonstrates how high-purity Diclofenac supports reproducible, data-rich inflammation and pain pathway studies.

• PP 2 (AG 1879): Selective Src Family Kinase Inhibitor for...

  2026-04-09

  PP 2 (AG 1879) is a potent, selective Src family kinase inhibitor widely used in cancer research and immune cell signaling studies. Its nanomolar-range efficacy and well-characterized kinase selectivity make it a benchmark compound for dissecting Src-mediated pathways. This article presents atomic, verifiable facts about its mechanism, benchmarks, and proper experimental integration.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page